Celldex Therapeutics (CLDX) stock price, chart and financials
Price chart
Financials
- Revenue (trailing twelve months)
- $158,000.00
- Revenue (quarter)
- $22,000.00
- Gross profit (trailing twelve months)
- $158,000.00
- Gross margin
- 100.00%
- Net income (quarter)
- −$73.5M
- Net margin
- −190220.89%
- Return on equity
- −43.88%
- Book value per share
- $9.10
- Price to book
- 4.30
- Debt to assets
- 8.66%
Frequently asked questions
Is Celldex Therapeutics (CLDX) profitable?
No. Celldex Therapeutics reported a net loss of $300.5M over the trailing twelve months.
How much revenue does Celldex Therapeutics (CLDX) make?
Celldex Therapeutics generated $158,000.00 in revenue over the trailing twelve months, down 96.99% year over year.
How do I buy stock in Celldex Therapeutics (CLDX)?
CLDX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
